CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Solon Eiendom ASA Company Snapshot
Solon Eiendom ASA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Solon Eiendom ASA with three other pharmaceutical manufacturers in Europe: OptiBiotix Health PLC of the United Kingdom (2015 sales of £28,200.00 [US$34,900.88 ] ), Futura Medical PLC of the United Kingdom (£29,476.00 [US$36,480.09 ] of which 100% was Pharmaceuticals), and Index Pharmaceuticals Holding Ab which is based in Sweden (376,000.00 Swedish Kronor [US$42,303.76 ] ).

Sales Analysis. Sales fell dramatically in 2015: During the year ended December of 2015, sales at Solon Eiendom ASA were NOK 85,000.00 (US$10.10 thousand). This is a sharp decrease of 95.2% versus 2014, when the company's sales were NOK 1.77 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Solon Eiendom ASA
  Stock Performance Chart for Solon Eiendom ASA
 
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): .15
(Figures in Norwegian Kroner)
1 Week 7.1%   13 Weeks 0.0%  
4 Weeks -23.2%   52 Weeks -52.9%  
 
Solon Eiendom ASA Key Data:
  Ticker: SOLON Country: Norway
  Exchanges: FRA LON OSL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 85,000
(Year Ending Jan 2016).
Employees: 13
  Currency: Norwegian Kroner Market Cap: 145,473,485
  Fiscal Yr Ends: December Shares Outstanding: 969,823,230
  Share Type: Ordinaere Aksje Closely Held Shares: 560,415,724
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.